646 results on '"Van den Hoogen, F"'
Search Results
2. Oorsuizen
3. TGFβ-mediated expression of TGFβ-activating integrins in SSc monocytes: disturbed activation of latent TGFβ?
4. Oorsuizen
5. Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
6. POS0078 COMPARING METHOTREXATE MONOTHERAPY WITH METHOTREXATE PLUS LEFLUNOMIDE COMBINATION THERAPY IN PSORIATIC ARTHRITIS: A RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL (COMPLETE-PsA)
7. POS0652 LONG-TERM EFFECTIVENESS OF ULTRA-LOW DOSES OF RITUXIMAB IN RHEUMATOID ARTHRITIS
8. OP0261 TREAT-TO-TARGET DOSE REDUCTION AND WITHDRAWAL STRATEGY OF TNF INHIBITORS IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL
9. POS0646 NON-MEDICAL SWITCHING FROM TOCILIZUMAB TO SARILUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY
10. Additional file 1 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
11. Additional file 3 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
12. Additional file 2 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
13. Additional file 4 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
14. Oorsuizen
15. The use of gentamicin-impregnated collagen sponges (Garacol®/Duracoll®) in cochlear implant infections: our experience in four cases
16. Response to: ‘Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?’ by Jan Damoiseaux
17. Acute upper airway failure and mediastinal emphysema following a wire-guided percutaneous cricothyrotomy in a patient with severe maxillofacial trauma
18. Effect ot the Dr. Bart application on healthcare use and clinical outcomes in people with osteoarthritis of the knee and/or hip in the Netherlands: A randomized controller trial
19. Economic evaluation of the Dr. Bart app in people with knee and/or hip osteoarthritis
20. Use and usability of the Dr. Bart app and its relation withc clinical outcomes in people with knee and/or hip osteoarthritis
21. Behandlung der systemischen Sklerose
22. Autologous hematopoietic stem cell transplantation for autoimmune diseases
23. POS0343 RITUXIMAB IS SUPERIOR TO PLACEBO IN POLYMYALGIA RHEUMATICA
24. POS0193 DAS28-CRP GUIDED TREAT-TO-TARGET TAPERING OF TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS: A RETROSPECTIVE COHORT STUDY.
25. Use and usability of the Dr. Bart app and its relation with health care utilization and clinical outcomes in people with knee and/or hip osteoarthritis
26. Economic evaluation of the Dr. Bart app in people with knee and/or hip osteoarthritis
27. Salivary duct ligation for anterior and posterior drooling: Our experience in twenty-one children
28. Giant laryngoceles: a cause of upper airway obstruction
29. Report from the EULAR ACR Scleroderma Classification Criteria Committee
30. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres
31. THU0412 EFFECT OF METFORMIN ON CLINICAL GOUT OUTCOMES IN GOUT PATIENTS WITH DIABETES MELLITUS
32. FRI0209 EFFECTS OF ADD-ON METHOTREXATE IN POLYMYALGIA RHEUMATICA PATIENTS: A RETROSPECTIVE STUDY
33. FRI0629-HPR USE AND USABILITY OF THE DR. BART APP AND ITS RELATION WITH CLINICAL OUTCOMES IN PEOPLE WITH KNEE AND/OR HIP OSTEOARTHRITIS
34. AB0505 SEASONAL INFLUENCE IN PMR: NOT ONLY SUMMER, BUT WINTER IS COMING TOO
35. AB0582 DIAGNOSING SYSTEMIC SCLEROSIS WITH PHOTOACOUSTIC AND HIGH-FREQUENCY ULTRASOUND IMAGING
36. OP0072 IDENTIFYING POLYMYALGIA RHEUMATICA RELAPSE AND ITS ASSOCIATIONS IN A RETROSPECTIVE COHORT
37. OP0155-HPR EFFECT OF THE DR. BART APPLICATION ON HEALTHCARE USE AND CLINICAL OUTCOMES IN PEOPLE WITH OSTEOARTHRITIS OF THE KNEE AND / OR HIP IN THE NETHERLANDS; A RANDOMIZED CONTROLLED TRIAL
38. AB1314-HPR ECONOMIC EVALUATION OF THE DR. BART APP IN PEOPLE WITH KNEE AND/OR HIP OSTEOARTHRITIS
39. THU0448 NO DIFFERENCE IN GOUT FLARES AFTER INITIATION OF URATE LOWERING THERAPY BETWEEN ONCE OR TWICE DAILY 0.5 MG COLCHICINE PROPHYLAXIS
40. Oorsuizen
41. Systemic sclerosis: State of the art on clinical practice guidelines
42. Fall incidence and fall risk factors in people with rheumatoid arthritis
43. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
44. A large multicentre analysis of CTGF −945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype
45. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
46. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy
47. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study
48. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
49. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study
50. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.